Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-19T20:21:06.765Z Has data issue: false hasContentIssue false
  • English
  • Français

Vortioxetine Efficiency in Controlling Obsessive Symptoms in Patients with Depression. A Case Report

Published online by Cambridge University Press:  23 March 2020

G. Pardo de Santayana ,
R. Landera ,
M. Juncal ,
O. Porta ,
L. Sánchez ,
M. Gómez ,
N. Núñez  and
M. Pérez
G. Pardo de Santayana
Affiliation:
Hospital Universitario Marqués de Valdecilla, Psychiatry, Santander, Spain
R. Landera
Affiliation:
Hospital Universitario Marqués de Valdecilla, Psychiatry, Santander, Spain
M. Juncal
Affiliation:
Hospital Universitario Marqués de Valdecilla, Psychiatry, Santander, Spain
O. Porta
Affiliation:
Hospital Universitario Marqués de Valdecilla, Psychiatry, Santander, Spain
L. Sánchez
Affiliation:
Hospital Universitario Marqués de Valdecilla, Psychiatry, Santander, Spain
M. Gómez
Affiliation:
Hospital Universitario Alava-Sede Santiago, Psychiatry, Vitoria-Gasteiz, Spain
N. Núñez
Affiliation:
Hospital Universitario Alava-Sede Santiago, Psychiatry, Vitoria-Gasteiz, Spain
M. Pérez
Affiliation:
Hospital Universitario Marqués de Valdecilla, Psychiatry, Santander, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Obsessive symptomatology can sometimes be worsened when a patient with this personality trait suffers through a period of increased stress.

Aim

To review articles in PubMed related to how vorticoxetine affects obsessive symptoms in patients with depression.

Methods

We review the case of a 45-year-old male with obsessive personality traits diagnosed of recurrent depression. He was going through a period of stress at work that had worsened his obsessive symptoms (primarily obsessive thoughts). In a previous depressive episode, he was treated with an antidepressant that triggered sexual dysfunction as a side effect. Trying to prevent another antidepressant-induce sexual dysfunction, we decided to use voricoxetine because of its low tendency to interact with the sexual function.

Results

We started treatment with vorticoxetine reaching a dose of 10 mg/day. Three weeks later the patient reported a decrease in his levels of anxiety, a slight upturn of his mood and a relieve of his obsessive symptoms.

Conclusions

Vorticoxetine can be considered a good therapeutic option in the treatment of obsessive symptoms in a depressive episode with patients with a history of antidepressant-induce sexual dysfunction.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster Viewing: Personality and personality disorders
Information
European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S715
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.